T 207 100 (Sirturo 100 mg)
Generic Name: bedaquiline
Pill with imprint T 207 100 is White, Round and has been identified as Sirturo 100 mg. It is supplied by Janssen Research & Development, LLC.
Sirturo is used in the treatment of tuberculosis, resistant and belongs to the drug class diarylquinolines. There is no proven risk in humans during pregnancy. Sirturo 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for T 207 100
Sirturo
- Generic Name
- bedaquiline
- Imprint
- T 207 100
- Strength
- 100 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Diarylquinolines
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Janssen Research & Development, LLC
- National Drug Code (NDC)
- 59676-0701
- Inactive Ingredients
-
corn starch,
silicon dioxide,
croscarmellose sodium,
hypromellose 2910 (15 mPa.s),
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
polysorbate 20,
water
Note: Inactive ingredients may vary.
More about Sirturo (bedaquiline)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Imprints, shape & color data
- Pricing & coupons
- En español
- Drug class: diarylquinolines
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.